MedPath

Serum Tryptase Concentration During General Anaesthesia With Rocuronium

Not Applicable
Completed
Conditions
Hypersensitivity Reaction
Interventions
Drug: general volatile anaesthesia
Registration Number
NCT04035707
Lead Sponsor
Medical University of Bialystok
Brief Summary

Rocuronium is a aminosteroid structured, non-depolarizing neuromuscular blocking agents (NMB). Epidemiological data presents that the frequency of hypersensitivity reactions caused by rocuronium have been increased. Determinations of serum tryptase concentrations are interdisciplinary recommended in diagnosis of its adverse reactions. No studies have been performed to explain specific role of rocuronium doses on serum tryptase values. The aim of this study was to investigate the potential effect of rocuronium on serum tryptase concentrations.

Detailed Description

The greatest risk of hypersensitivity occurs during anesthesia for female patients and it is connected with the induction phase using skeletal muscle relaxants . Epidemiological data presents that the frequency of hypersensitivity reactions caused by rocuronium have been increased. Due to the multiple advantages reports of triggering allergic or hypersensitivity reactions caused by rocuronium create doubts about the safety of application .

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
126
Inclusion Criteria
  • ASA 1-2, no allergy and perioperative hypersensitivity reactions during anaesthesia
Exclusion Criteria
  • steroid therapy, allergy in medical history, mastocytosis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
anaesthesia with rocuroniumRocuroniumrocuronium is used during anaesthesia
anaesthesia with rocuroniumgeneral volatile anaesthesiarocuronium is used during anaesthesia
anaesthesia without rocuroniumgeneral volatile anaesthesiaduring anaesthesia rocuronium is not used
Primary Outcome Measures
NameTimeMethod
tryptaseup to 40 minutes after surgery

serum tryptase concentration

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath